HK1170533A1 - Process for production of cytokine-induced killer cells - Google Patents

Process for production of cytokine-induced killer cells

Info

Publication number
HK1170533A1
HK1170533A1 HK12111301.7A HK12111301A HK1170533A1 HK 1170533 A1 HK1170533 A1 HK 1170533A1 HK 12111301 A HK12111301 A HK 12111301A HK 1170533 A1 HK1170533 A1 HK 1170533A1
Authority
HK
Hong Kong
Prior art keywords
cytokine
production
killer cells
induced killer
induced
Prior art date
Application number
HK12111301.7A
Inventor
Meiko Jin
Mitsuko Ideno
Tatsuji Enoki
Original Assignee
Takara Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takara Bio Inc filed Critical Takara Bio Inc
Publication of HK1170533A1 publication Critical patent/HK1170533A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/24—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/515—CD3, T-cell receptor complex

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK12111301.7A 2009-10-28 2012-11-08 Process for production of cytokine-induced killer cells HK1170533A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009247347 2009-10-28
PCT/JP2010/069072 WO2011052638A1 (en) 2009-10-28 2010-10-27 Process for production of cytokine-induced killer cells

Publications (1)

Publication Number Publication Date
HK1170533A1 true HK1170533A1 (en) 2013-03-01

Family

ID=43922063

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12111301.7A HK1170533A1 (en) 2009-10-28 2012-11-08 Process for production of cytokine-induced killer cells

Country Status (4)

Country Link
JP (1) JP5097856B2 (en)
CN (1) CN102575231B (en)
HK (1) HK1170533A1 (en)
WO (1) WO2011052638A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103642752A (en) * 2013-12-04 2014-03-19 深圳市合一康生物科技有限公司 Preparation method of human CD3+CD8+CIK (cytokine induced killer) cells
CN103756960A (en) * 2013-12-04 2014-04-30 深圳市合一康生物科技有限公司 Special kit for high-toxicity and high-value-adding-capability human D-CIK cells
CN103642754A (en) * 2013-12-04 2014-03-19 深圳市合一康生物科技有限公司 Preparation method of human D-CIK (dendritic cell activated and cytokine induced killer) cell with high toxicity and high value-adding capacity
CN103642753A (en) * 2013-12-04 2014-03-19 深圳市合一康生物科技有限公司 Special kit for preparing human CD3+CD8+CIK (cytokine induced killer) cells
CN107267383A (en) * 2013-12-18 2017-10-20 东洋制罐集团控股株式会社 The manufacture method and immobilization device of culture vessel
CN106011059A (en) * 2016-06-03 2016-10-12 福州市传染病医院 Method for enrichment culture of high-purity CD56 positive cells
WO2018053463A1 (en) 2016-09-19 2018-03-22 H. Lee Moffitt Cancer Center And Research Institute, Inc. Artificial antigen presenting cells for genetic engineering of immune cells
US20200181260A1 (en) * 2017-02-22 2020-06-11 H. Lee Moffitt Cancer Center And Research Institute, Inc. Bispecific antibody for cancer immunotherapy
CN107812013B (en) * 2017-10-20 2020-07-28 胥萍 Biological preparation for treating drug-resistant tuberculosis and preparation method thereof
KR102577954B1 (en) * 2018-07-10 2023-09-14 이뮤너티바이오, 인크. Generation of CIK NKT cells from umbilical cord blood
CN113957051B (en) * 2021-11-24 2023-08-25 广东齐美生命医学技术研究院 CIK cell culture medium and culture method
CN115651905B (en) * 2022-11-16 2023-06-16 南京鼓楼医院 Staged culture method for in-vitro amplification of human CIK cells and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101037668B (en) * 2007-03-01 2010-09-22 常州市第一人民医院 Lymphocyte cultivation liquid and methodfor culturing CIK cell
CN101063108A (en) * 2007-04-25 2007-10-31 哈尔滨医科大学 Preparation method for CIK cell with high proliferation and high cell cytotoxic activity
CN101580817A (en) * 2008-05-16 2009-11-18 宝生物工程株式会社 Method for preparing cell group containing cytokine-induced killing cell

Also Published As

Publication number Publication date
WO2011052638A1 (en) 2011-05-05
JP5097856B2 (en) 2012-12-12
CN102575231B (en) 2013-09-11
CN102575231A (en) 2012-07-11
JPWO2011052638A1 (en) 2013-03-21

Similar Documents

Publication Publication Date Title
EP2476752A4 (en) Process for production of natural killer cells
HK1170533A1 (en) Process for production of cytokine-induced killer cells
PT2913337T (en) Process for the production of sofosbuvir
HK1178688A1 (en) Process for production of connected structure
EP2441831A4 (en) Process for production of protein
PL2319984T3 (en) Process for production of paper
EP2449121A4 (en) Alcohol production process
EP2433311A4 (en) Process for improving the production of photovoltaic products
EP2391724A4 (en) Alcohol production process
EP2319800A4 (en) Process for production of hexafluorophosphates
ZA201107805B (en) Process for the production of alcohols
PL2462088T3 (en) Process for the production of methane
EP2294045A4 (en) Process for production of glycolic acid
EP2395096A4 (en) Process for producing l-amino acid
EP2518089A4 (en) Process for production of syndiotactic -olefin polymer
EP2439312A4 (en) Process for production of reduced glutathione
EP2471943A4 (en) Process for production of l-amino acid
EP2401386A4 (en) Improved methods for fermentative production of docosahexaenoic acid
EP2580339A4 (en) System and process for production of biofuels
EP2623580A4 (en) Process for production of beta-sialon
EP2471942A4 (en) Process for production of l-amino acid
EP2133356A4 (en) Process for production of phosphorus-containing -keto acid
EP2292579A4 (en) Process for production of halogenated -fluoroethers
EP2319799A4 (en) Process for production of hydrogen
EP2581148A4 (en) Process for production of molds

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20171027